Skip to main content
$121.55 $11.55 (10.5%)

01:00 PM EST on 11/27/20

CRISPR Therapeutics (NASDAQ:CRSP)

CAPS Rating: 4 out of 5

Current Price $121.55 Mkt Cap $8.6B
Open $111.08 P/E Ratio 0.00
Prev. Close $121.55 Div. (Yield) $0.00 (0.0%)
Daily Range $110.36 - $124.43 Volume 1,124,306
52-Wk Range $32.30 - $124.43 Avg. Daily Vol. 1,062,108

Caps

How do you think NASDAQ:CRSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

268 Outperform
5 Underperform
 

All-Star Players

148 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CRSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

dcclf (< 20)
Submitted November 01, 2019

Crispr Therapeutics AG (CRSP) is a very professional outfit. Since its de novo in late 2016, the company has always presented itself in the most intelligible, concise, and scrupulous manner. From international conference presentations to downloadable… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CRSP VS S&P 500 (SPY)

NASDAQ:CRSP Summary

Fools bullish on NASDAQ:CRSP are also bullish on:

Fools bearish on NASDAQ:CRSP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRSP.

Recs

0
Member Avatar In2b8er (58.20) Submitted: 11/15/2020 1:44:32 PM : Outperform Start Price: $105.85 NASDAQ:CRSP Score: +14.09

Heard about this stock in mid 2019 on a MF podcast. No regret in this cutting edge technology.

Recs

0
Member Avatar JedLloren (56.50) Submitted: 10/23/2020 12:40:33 PM : Outperform Start Price: $90.81 NASDAQ:CRSP Score: +28.07

I really believe in CRISPR technology. Of course, this industry is still a very speculative area. However, if companies are able to create reliable therapies using this tech, it will truly be life changing. CRSP is the bona fide leader in this area.

Recs

0
Member Avatar wpshil78 (34.49) Submitted: 10/9/2020 10:37:47 AM : Outperform Start Price: $99.64 NASDAQ:CRSP Score: +16.69

Wild valuation. But the Nobel just got awarded to 2 founders. Do you think that DNA slicing may have market potential?

Leaderboard

Find the members with the highest scoring picks in CRSP.

Score Leader

CMFMLove

CMFMLove (86.06) Score: +713.00

I'm generally bad at CAPS but I may have gotten this pick right. There's a long way to go, however, until we see commercial results from this technology.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CMFMLove 86.06 6/13/2017 Outperform 5Y $14.10 +762.06% +49.06% +713.00 1 Comment
Momentum21 89.62 10/24/2016 Outperform 5Y $14.05 +765.12% +69.32% +695.80 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $15.13 +703.37% +48.99% +654.38 0 Comment
prankjt17530 67.30 2/13/2017 Outperform 5Y $15.21 +699.15% +56.70% +642.45 0 Comment
SHOPNVDA < 20 6/26/2017 Outperform 5Y $16.84 +621.79% +49.11% +572.69 0 Comment
Capitalism 93.28 5/15/2017 Outperform 5Y $17.05 +612.90% +51.45% +561.45 1 Comment
TMFFishBiz 63.88 11/13/2017 Outperform 5Y $17.91 +578.67% +40.80% +537.87 0 Comment
JF9383 82.95 12/6/2017 Outperform 5Y $18.44 +559.16% +38.35% +520.82 0 Comment
jeepdrew222 86.58 12/12/2017 Outperform 5Y $18.61 +553.14% +36.43% +516.72 0 Comment
portefeuille 98.72 3/27/2017 Outperform 5Y $18.50 +557.03% +56.80% +500.23 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRSP.